Drug Type Small molecule drug |
Synonyms LY-213735 |
Target- |
Mechanism- |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H16ClN3O5 |
InChIKeyKRMIFMBCMNQMJH-UTUOFQBUSA-N |
CAS Registry76609-94-4 |